9-(2-hydroxy-3-nonyl)adenine has been researched along with Kidney Failure, Chronic in 1 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smoleński, RT | 1 |
| Marlewski, M | 1 |
1 other study available for 9-(2-hydroxy-3-nonyl)adenine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Degradation of adenine nucleotides in the erythrocytes of patients with chronic renal failure.
Topics: Adenine; Adenine Nucleotides; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Erythrocytes; Hum | 1990 |